Advertisement
Review Article| Volume 43, ISSUE 4, P811-820, December 2022

Family Planning and Reproductive Health in Cystic Fibrosis

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • World Health Organization (WHO)
        Contraception.
        (Available at:) (Accessed October 5, 2021)
      1. Cystic Fibrosis Foundation patient Registry report 2019.
        (Available at:) (Accessed October 5, 2021)
        • Leech M.M.
        • Stransky O.M.
        • Talabi M.B.
        • et al.
        Exploring the reproductive decision support needs and preferences of women with cystic fibrosis.
        Contraception. 2021; 103: 32-37
        • Sawyer S.M.
        • Phelan P.D.
        • Bowes G.
        Reproductive health in young women with cystic fibrosis: knowledge, behavior and attitudes.
        J Adolesc Health. 1995; 17: 46-50
        • Kazmerski T.M.
        • Sawicki G.S.
        • Miller E.
        • et al.
        Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis.
        J Cyst Fibros. 2018; 17: 57-63
        • Britto M.T.
        • Garrett J.M.
        • Dugliss M.A.J.
        • et al.
        Risky behavior in teens with cystic fibrosis or sickle cell disease: a multicenter study.
        Pediatrics. 1998; 101: 250-256
        • Dodd M.E.
        • Langman H.
        Urinary incontinence in cystic fibrosis.
        J R Soc Med. 2005; 98: 28-36
        • Chambers R.
        • Lucht A.
        • Reihill A.
        • et al.
        Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: a questionnaire survey.
        Int Urogynecol J. 2017; 28: 591-604
        • Mariani A.
        • Gambazza S.
        • Carta F.
        • et al.
        Prevalence and factors associated with urinary incontinence in females with cystic fibrosis: an Italian single-centre cross-sectional analysis.
        Pediatr Pulmonol. 2021; https://doi.org/10.1002/ppul.25723
        • Kazmerski T.M.
        • Nelson E.
        • Newman L.R.
        • et al.
        Talking about sex: the training wants and needs of the CF interprofessional team. Conference Abstract.
        Pediatr Pulmonol. 2018; 53: 444-445
        • Neemuchwala F.
        • Ahmed F.
        • Nasr S.Z.
        Prevalence of pelvic incontinence in patients with cystic fibrosis.
        Glob Pediatr Health. 2017; 4 (2333794x17743424)
        • Wilschanski M.
        • Corey M.
        • Durie P.
        • et al.
        Diversity of reproductive tract abnormalities in men with cystic fibrosis.
        JAMA. 1996; 276: 607-608
        • Orr A.
        • McVean R.J.
        • Webb A.K.
        • et al.
        Questionnaire survey of urinary incontinence in women with cystic fibrosis.
        BMJ. 2001; 322: 1521
        • Moran F.
        • Bradley J.M.
        • Boyle L.
        • et al.
        Incontinence in adult females with cystic fibrosis: a Northern Ireland survey.
        Int J Clin Pract. 2003; 57: 182-183
        • Gumery L.
        • Lee J.
        • Whitehouse J.
        • et al.
        The prevalence of urinary incontinence in adult cystic fibrosis males.
        J Cyst Fibros. 2005; 4: S97
        • Sawyer S.M.
        • Farrant B.
        • Cerritelli B.
        • et al.
        A survey of sexual and reproductive health in men with cystic fibrosis: new challenges for adolescent and adult services.
        Thorax. 2005; 60: 326-330
        • Kazmerski T.M.
        • Prushinskaya O.V.
        • Hill K.
        • et al.
        Sexual and reproductive health of young women with cystic fibrosis: a concept mapping study.
        Acad Pediatr. 2019; 19: 307-314
        • Malouf M.A.
        • Hopkins P.M.
        • Singleton L.
        • et al.
        Sexual health issues after lung transplantation: importance of cervical screening.
        J Heart Lung Transplant. 2004; 23: 894-897
        • Rousset-Jablonski C.
        • Reynaud Q.
        • Nove-Josserand R.
        • et al.
        High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis.
        Eur J Obstet Gynecol Reprod Biol. 2018; 221: 40-45
        • Rousset Jablonski C.
        • Reynaud Q.
        • Perceval M.
        • et al.
        Contraceptive practices and cervical screening in women with cystic fibrosis.
        Hum Reprod. 2015; 30: 2547-2551
        • Arbyn M.
        • Xu L.
        • Simoens C.
        • et al.
        Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
        Cochrane Database Syst Rev. 2018; 5: CD009069
        • Moscicki A.B.
        • Flowers L.
        • Huchko M.J.
        • et al.
        Guidelines for cervical cancer screening in immunosuppressed women without HIV infection.
        J Low Genit Tract Dis. 2019; 23: 87-101
        • Kazmerski T.M.
        • Gmelin T.
        • Slocum B.
        • et al.
        Attitudes and decision making related to pregnancy among young women with cystic fibrosis.
        Matern child Health J. 2017; 21: 818-824
        • Korzeniewska A.
        • Grzelewski T.
        • Jerzynska J.
        • et al.
        Sexual and reproductive health knowledge in cystic fibrosis female patients and their parents.
        J Sex Med. 2009; 6: 770-776
        • Ashley Gage L.
        What deficits in sexual and reproductive health knowledge exist among women with cystic fibrosis? a systematic review.
        Health Social Work. 2012; 37: 29-36
        • Jain R.
        • Kazmerski T.M.
        • Aitken M.L.
        • et al.
        Challenges faced by women with cystic fibrosis.
        Clin Chest Med. 2021; 42: 517-530
        • Roe A.H.
        • Traxler S.
        • Schreiber C.A.
        Contraception in women with cystic fibrosis: a systematic review of the literature. Review.
        Contraception. 2016; 93: 3-10
        • Whiteman M.K.
        • Oduyebo T.
        • Zapata L.B.
        • et al.
        Contraceptive safety among women with cystic fibrosis: a systematic review. Review.
        Contraception. 2016; 94: 621-629
        • Curtis K.M.
        • Tepper N.K.
        • Jatlaoui T.C.
        • et al.
        U.S. Medical eligibility criteria for contraceptive use, 2016.
        Mmwr Recommendations Rep. 2016; 65: 1-103
        • Conway S.P.
        Impact of lung inflammation on bone metabolism in adolescents with cystic fibrosis.
        Paediatr Respir Rev. 2001; 2: 324-331
        • Deerojanawong J.
        • Sawyer S.M.
        • Fink A.M.
        • et al.
        Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
        Thorax. 1998; 53: 285-289
        • Jones G.H.
        • Walshaw M.J.
        Potential impact on fertility of new systemic therapies for cystic fibrosis.
        Paediatr Respir Rev. 2015; 16: 25-27
        • Incorporated V.P.
        Lumacaftor/ivacaftor (Orkambi) United States prescribing information.
        2018 (Available at:) (Accessed October 5, 2021)
        • Incorporated V.P.
        Elexacaftor/tezacaftor/ivacaftor (Trikafta) United States prescribing information. Updated October 2021.
        (Available at:) (Accessed October 5, 2021)
        • Incorporated V.P.
        Tezacaftor/ivacaftor (Symdeko) United States prescribing information.
        (Available at:) (Accessed October 5, 2021)
        • Incorporated V.P.
        Ivacaftor (Kalydeco) United States prescribing information updated 9/2020.
        (Available at:) (Accessed October 5, 2021)
        • Thorpe-Beeston J.G.
        • Madge S.
        • Gyi K.
        • et al.
        The outcome of pregnancies in women with cystic fibrosis-single centre experience 1998-2011.
        BJOG. 2013; 120: 354-361
        • Edenborough F.P.
        • Borgo G.
        • Knoop C.
        • et al.
        Guidelines for the management of pregnancy in women with cystic fibrosis.
        J Cyst Fibros. 2008; 7: S2-S32
        • Cohen-Cymberknoh M.
        • Gindi Reiss B.
        • Reiter J.
        • et al.
        Baseline Cystic fibrosis disease severity has an adverse impact on pregnancy and infant outcomes, but does not impact disease progression.
        J Cyst Fibros. 2021; 20: 388-394
        • Reynaud Q.
        • Rousset Jablonski C.
        • Poupon-Bourdy S.
        • et al.
        Pregnancy outcome in women with cystic fibrosis and poor pulmonary function.
        J Cyst Fibros. 2020; 19: 80-83
        • Canny G.J.
        • Corey M.
        • Livingstone R.A.
        • et al.
        Pregnancy and cystic fibrosis.
        Obstet Gynecol. 1991; 77: 850-853
        • Kotloff R.M.
        • FitzSimmons S.C.
        • Fiel S.B.
        Fertility and pregnancy in patients with cystic fibrosis. Review.
        Clin Chest Med. 1992; 13: 623-635
        • McArdle J.R.
        Pregnancy in cystic fibrosis. Review.
        Clin Chest Med. 2011; 32: 111-120
        • McDonald C.M.
        • Alvarez J.A.
        • Bailey J.
        • et al.
        Academy of nutrition and Dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline.
        J Acad Nutr Diet. 2021; 121: 1591-1636.e3
        • Cheng E.Y.
        • Goss C.H.
        • McKone E.F.
        • et al.
        Aggressive prenatal care results in successful fetal outcomes in CF women.
        J Cyst Fibros. 2006; 5: 85-91
        • Rothman K.J.
        • Moore L.L.
        • Singer M.R.
        • et al.
        Teratogenicity of high vitamin A intake.
        N Engl J Med. 1995; 333: 1369-1373
        • Ashcroft A.
        • Chapman S.J.
        • Mackillop L.
        The outcome of pregnancy in women with cystic fibrosis: a UK population-based descriptive study.
        BJOG. 2020; 127: 1696-1703
      2. Raksha Jain AK, MinJae Lee, Natalie West, Traci M. Kazmersk, Moira Aitke, Andrea H. Roe, Denis Hadjiliadis, Ahmet Uluer, Sheila Mody, Patrick Flume, Leigh Ann Bray, Jennifer Taylor-Cousar. Effect of pregnancy on lung function: impact of CFTR modulators. presented at: NACFC; 2021; North American CF Conference, held virtually, October 2021.

        • Thomas E.
        • Yang J.
        • Xu J.
        • et al.
        Pulmonary hypertension and pregnancy outcomes: Insights from the National Inpatient sample.
        J Am Heart Assoc. 2017; 6https://doi.org/10.1161/JAHA.117.006144
        • Ludvigsson J.F.
        • Neovius M.
        • Soderling J.
        • et al.
        Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden.
        BMJ. 2018; 362: k2638
        • Guerin A.
        • Nisenbaum R.
        • Ray J.G.
        Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes.
        Diabetes Care. 2007; 30: 1920-1925
      3. Committee Opinion No. 691: carrier screening for genetic conditions.
        Obstet Gynecol. 2017; 129: e41-e55
        • Beauchamp K.A.
        • Johansen Taber K.A.
        • Grauman P.V.
        • et al.
        Sequencing as a first-line methodology for cystic fibrosis carrier screening.
        Genet Med. 2019; 21: 2569-2576
        • Deignan J.L.
        • Astbury C.
        • Cutting G.R.
        • et al.
        CFTR variant testing: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
        Genet Med. 2020; 22: 1288-1295
        • Boyd J.B.
        • Mehta A.
        • Murphy D.J.
        Fertility and pregnancy outcomes in men and women with cystic fibrosis in the United Kingdom.
        Hum Reprod. 2004; 19: 2238-2243
        • Gazvani R.
        • Lewis-Jones D.I.
        Cystic fibrosis mutation screening before assisted reproduction. Review.
        Int J Androl. 2004; 27: 1-4
        • Sueblinvong V.
        • Whittaker L.A.
        Fertility and pregnancy: common concerns of the aging cystic fibrosis population. Review.
        Clin Chest Med. 2007; 28: 433-443
        • Edenborough F.P.
        Women with cystic fibrosis and their potential for reproduction.
        Thorax. 2001; 56: 649-655
        • Ahmad A.
        • Ahmed A.
        • Patrizio P.
        Cystic fibrosis and fertility. Review.
        Curr Opin Obstet Gynecol. 2013; 25: 167-172
        • Tizzano E.F.
        • Silver M.M.
        • Chitayat D.
        • et al.
        Differential cellular expression of cystic fibrosis transmembrane regulator in human reproductive tissues. Clues for the infertility in patients with cystic fibrosis.
        Am J Pathol. 1994; 144: 906-914
        • Hayslip C.C.
        • Hao E.
        • Usala S.J.
        The cystic fibrosis transmembrane regulator gene is expressed in the human endocervix throughout the menstrual cycle.
        Fertil Steril. 1997; 67: 636-640
        • Ismail N.
        • Giribabu N.
        • Muniandy S.
        • et al.
        Estrogen and progesterone differentially regulate the levels of cystic fibrosis transmembrane regulator (CFTR), adenylate cyclase (AC), and cyclic adenosine mono-phosphate (cAMP) in the rat cervix.
        Mol Reprod Dev. 2015; 82: 463-474
        • Kopito L.E.
        • Kosasky H.J.
        • Shwachman H.
        Water and electrolytes in cervical mucus from patients with cystic fibrosis.
        Fertil Steril. 1973; 24: 512-516
        • Lyon A.
        • Bilton D.
        Fertility issues in cystic fibrosis. Review.
        Paediatr Respir Rev. 2002; 3: 236-240
        • Chan H.C.
        • Shi Q.X.
        • Zhou C.X.
        • et al.
        Critical role of CFTR in uterine bicarbonate secretion and the fertilizing capacity of sperm.
        Mol Cell Endocrinol. 2006; 250: 106-113
        • Khan F.N.
        • Tangpricha V.
        • Hughan K.S.
        • et al.
        Men's health in the modern era of cystic fibrosis.
        J Cyst Fibros. 2020; https://doi.org/10.1016/j.jcf.2020.12.013
        • Heltshe S.L.
        • Godfrey E.M.
        • Josephy T.
        • et al.
        Pregnancy among cystic fibrosis women in the era of CFTR modulators.
        J Cyst Fibros. 2017; 16: 687-694
        • Ladores S.
        • Kazmerski T.M.
        • Rowe S.M.
        A case report of pregnancy during use of Targeted Therapeutics for cystic fibrosis.
        J Obstet Gynecol neonatal Nurs. 2017; 46: 72-77
        • Coward R.M.
        • Mills J.N.
        A step-by-step guide to office-based sperm retrieval for obstructive azoospermia.
        Transl Androl Urol. 2017; 6: 730-744
        • Esteves S.C.
        • Miyaoka R.
        • Agarwal A.
        Sperm retrieval techniques for assisted reproduction.
        Int Braz J Urol. 2011; 37: 570-583
        • Kredentser J.V.
        • Pokrant C.
        • McCoshen J.A.
        Intrauterine insemination for infertility due to cystic fibrosis.
        Fertil Sterility. 1986; 45: 425-426
        • Medical Advisory S.
        In vitro fertilization and multiple pregnancies: an evidence-based analysis.
        Ont Health Technol Assess Ser. 2006; 6: 1-63
        • Nandi A.
        • Raja G.
        • White D.
        • et al.
        Intrauterine insemination + controlled ovarian hyperstimulation versus in vitro fertilisation in unexplained infertility: a systematic review and meta-analysis.
        Arch Gynecol Obstet. 2021; https://doi.org/10.1007/s00404-021-06277-3
      4. Cystic fibrosis Foundation patient Registry report 2020.
        (Available at:) (Accessed October 5, 2021)
        • Middleton P.G.
        • Gade E.J.
        • Aguilera C.
        • et al.
        ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases.
        Eur Respir J. 2020; 55 (no pagination)1901208
        • Kazmerski T.M.
        • West N.E.
        • Jain R.
        • et al.
        Family-building and parenting considerations for people with cystic fibrosis. Review.
        Pediatr Pulmonol. 2021; https://doi.org/10.1002/ppul.25620
        • Jain R.
        • Kazmerski T.M.
        • Zuckerwise L.C.
        • et al.
        Pregnancy in cystic fibrosis: review of the literature and expert recommendations. Review.
        J Cyst Fibros. 2021; https://doi.org/10.1016/j.jcf.2021.07.019
        • Ramsey B.W.
        • Davies J.
        • McElvaney N.G.
        • et al.
        A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
        N Engl J Med. 2011; 365: 1663-1672
        • Middleton P.G.
        • Mall M.A.
        • Drevinek P.
        • et al.
        Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
        N Engl J Med. 2019; 381: 1809-1819
        • Heijerman H.G.M.
        • McKone E.F.
        • Downey D.G.
        • et al.
        Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.
        Lancet. 2019; 394: 1940-1948
        • Accurso F.J.
        • Rowe S.M.
        • Clancy J.P.
        • et al.
        Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
        N Engl J Med. 2010; 363: 1991-2003
        • Rowe S.M.
        • Daines C.
        • Ringshausen F.C.
        • et al.
        Tezacaftor-ivacaftor in residual-function heterozygotes with cystic fibrosis.
        N Engl J Med. 2017; 377: 2024-2035
        • Trimble A.
        • McKinzie C.
        • Terrell M.
        • et al.
        Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding.
        J Cyst Fibros. 2018; 17: 779-782
        • Nash E.F.
        • Middleton P.G.
        • Taylor-Cousar J.L.
        Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators - an international survey.
        J Cyst Fibros. 2020; 19: 521-526
        • Taylor-Cousar J.L.
        • Jain R.
        Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation.
        J Cyst Fibros. 2021; 20: 402-406
        • Jacob A.
        • Journiac J.
        • Fischer L.
        • et al.
        How do cystic fibrosis patients experience parenthood? A systematic review.
        J Health Psychol. 2021; 26: 60-81
        • Hailey C.E.
        • Tan J.W.
        • Dellon E.P.
        • et al.
        Pursuing parenthood with cystic fibrosis: reproductive health and parenting concerns in individuals with cystic fibrosis.
        Pediatr Pulmonol. 2019; 54: 1225-1233
        • Barker H.
        • Moses J.
        • O'Leary C.
        'I've got to prioritise': being a parent with cystic fibrosis.
        Psychol Health Med. 2017; 22: 744-752
        • Goss C.H.
        • Rubenfeld G.D.
        • Otto K.
        • et al.
        The effect of pregnancy on survival in women with cystic fibrosis.
        Chest. 2003; 124: 1460-1468
        • Schechter M.S.
        • Quittner A.L.
        • Konstan M.W.
        • et al.
        Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis.
        Ann Am Thorac Soc. 2013; 10: 213-219
        • Dugueperoux I.
        • Hubert D.
        • Dominique S.
        • et al.
        Paternity in men with cystic fibrosis: a retrospective survey in France.
        J Cyst Fibros. 2006; 5: 215-221
        • Bianco B.
        • Horsley A.
        • Brennan A.
        Implications of fatherhood in cystic fibrosis. Review.
        Paediatr Respir Rev. 2019; 31: 18-20
        • West N.E.
        • Kazmerski T.M.
        • Taylor-Cousar J.L.
        • et al.
        Optimizing sexual and reproductive health across the lifespan in people with cystic fibrosis.
        Pediatr Pulmonol. 2021; https://doi.org/10.1002/ppul.25703
        • Callegari L.S.
        • Aiken A.R.
        • Dehlendorf C.
        • et al.
        Addressing potential pitfalls of reproductive life planning with patient-centered counseling.
        Am J Obstet Gynecol. 2017; 216: 129-134
        • Borrero S.
        • Nikolajski C.
        • Steinberg J.R.
        • et al.
        It just happens": a qualitative study exploring low-income women's perspectives on pregnancy intention and planning.
        Contraception. 2015; 91: 150-156
        • Callegari L.S.
        • Aiken A.R.A.
        • Dehlendorf C.
        • et al.
        Reproductive life planning and patient-centered care: can the Inconsistencies be reconciled?.
        Matern Child Health J. 2019; 23: 869-870
        • Aiken A.R.
        • Borrero S.
        • Callegari L.S.
        • et al.
        Rethinking the pregnancy planning paradigm: unintended conceptions or unrepresentative concepts?.
        Perspect Sex Reprod Health. 2016; 48: 147-151
      5. Family Planning: Cystic Fibrosis and Reproductive Goals, Cystic Fibrosis Foundation; Bethesda, MD.

        • Stulberg D.B.
        • Datta A.
        • White VanGompel E.
        • et al.
        One key Question(R) and the desire to avoid pregnancy scale: a comparison of two approaches to asking about pregnancy preferences.
        Contraception. 2020; 101: 231-236
        • Ross L.J.
        Reproductive justice as Intersectional Feminist activism.
        Souls. 2017; 19: 286-314